BusinessCannabis Science Announces its Construction Project Management (CPMT) Teams in Support of the Company’s Initiative to Establish Pharmacies and Medical Centers in California and Throughout the U.S.By Nasdaq OMXJan 10, 2018, 6:08 PM UTC
BusinessCannabis Science Actively Pursuing U.S. Federal Government Contracts and Is Preparing Applications for Submission While Confirming the CBIS Security Team (CBISST) is Ready for ActionBy Nasdaq OMXJan 9, 2018, 5:07 PM UTC
BusinessCrown Bioscience Launches CrownSyn™, an Innovative Bioinformatics Solution that Simplifies the Characterization of Two-Drug Combination StudiesBy Nasdaq OMXJan 9, 2018, 1:00 PM UTC
BusinessPivot To Initiate Topical Product Development With Israel Based Research OrganizationsBy Nasdaq OMXJan 9, 2018, 12:02 PM UTC
BusinessSkipta and The Fresh Toast Partner to Bring Information and Advances in Cannabinoid Medicine to Healthcare ProfessionalsBy Nasdaq OMXJan 8, 2018, 4:34 PM UTC
BusinessNewLink Genetics Outlines 2018 Business Priorities to Support Phase 3 Pivotal Trial of Indoximod Plus PD-1 InhibitorsBy Nasdaq OMXJan 8, 2018, 1:03 PM UTC
BusinessBioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossificans ProgressivaBy Nasdaq OMXJan 5, 2018, 11:00 AM UTC
BusinessInspire and Antidote Launch End-to-End Clinical Trial Recruitment Solution to Accelerate Medical ResearchBy Nasdaq OMXJan 4, 2018, 12:00 PM UTC
